Blog Archives for tag treatment

Press Release – Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease

Today, Boehringer Ingelheim sent out a press release, announcing that, “… the European Commission (EC) and U.S. Food and Drug Administration… Continue reading »

worldcongress4_300

Videos from 4th Systemic Sclerosis World Congress

More than 300 patients participated the patient’s congress at 4th Systemic Sclerosis World Congress in Lisbon, February 18-20, 2016. We… Continue reading »

New therapies – AIMSPRO

The Food and Drug Administration has at the end of February 2014 granted Orphan Drug designation to the therapy AIMSPRO,… Continue reading »

DESSCIPHER – to decipher the optimal management of Systemic Sclerosis

Dear People with Systemic Sclerosis, On the 1st April 2013 the first international EU-funded research project “DeSScipher” started! WHAT IS… Continue reading »